CompletedNot Applicable

Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis

France264 participantsStarted 2010-01-19

Plain-language summary

Early diagnosis of liver fibrosis is useful for the follow-up and treatment of chronic liver disease. At present, the unique validated method to evaluate the liver fibrosis in children, is the liver biopsy which is an invasive method. If the elastometry method is proved to be a good method to evaluate the fibrosis in children, a numerous liver biopsy could be avoided.

Who can participate

Age range6 Months – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria : * Children age more than 6 months and under 18 years old. * Children with an hepatic biopsy for any fibrosis hepatitic diseases * Clinical examination by a physician Exclusion criteria : * Children of less than 6 months and more than 18 years old. * Pregnant women. * No written informed consent * No social security

What they're measuring

To study the diagnosis value of hepatic elasticity measured by FIBROSCANN ® about fibrosis degree in comparison with hepatic biopsy (GOLDSTANDART) in a paediatric hepatic diseases cohort.

Timeframe: until two months

Trial details

NCT IDNCT01072721

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-07-11

View on ClinicalTrials.gov More Cirrhosis trials